The Latest Breaking News from FDA

Here's Why Travere Therapeutics Shares Are Rising Today

Travere Therapeutics Inc (NASDAQ: TVTX) shares are trading higher by 7.66% at $23.88 after the company received a priority review from the FDA for its treatment of IgA Nephropathy.

Benzinga · May 16, 2022

Buffalo Shooting Will Prompt Measures 'To Combat Domestic Terrorism,' Says Pelosi

Plus: Netflix defends artistic expression, perspectives on the baby formula shortage, and more...

Reason · May 16, 2022

Chimerix Shares Plummet After Divesting Its Only Marketed Product For Over $300M

Emergent BioSolutions Inc (NYSE:EBS) has agreed to acquire Chimerix Inc's (NASDAQ:CMRX) exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.  "It exemplifies our thoughtful M&A strategy as part of our 2024 growth plan and positions us better to deliver value for our shareholders," said Robert Kramer, president…

Benzinga · May 16, 2022

Bette Midler faces backlash for telling mothers to ‘try breastfeeding’ their babies amid formula shortage

‘What a profoundly offensive and ignorant statement’

The Independent UK · May 13, 2022

Baby-formula shortage spurs US to prod Abbott over access

WASHINGTON — The Biden administration on Friday urged Abbott Laboratories to do more to ensure low-income families on federal assistance have access to baby formula, amid a nationwide shortage.

Tribune News Service · May 13, 2022

White House bolsters efforts to get baby formula into the hands of WIC recipients

States have been asked to increase accessibility of baby formula for recipients of the low-income program. And the Food and Drug Administration is looking at ways to make it easier to import formula.

WEKU · May 13, 2022

Why there is a baby formula crisis and what can be done about it

The formula shortage may continue for months.

Axios · May 13, 2022

After baby formula recall, Abbott says it can restart production at Michigan site within 2 weeks of FDA approval

Abbott Laboratories said it could have some of its recalled infant formulas back on store shelves within eight to 10 weeks after the U.S. Food and Drug Administration gives its approval, though it’s unclear when that approval may come.

Chicago Tribune · May 13, 2022

Imported infant formula could help lift U.S. supply in weeks -FDA chief

The Food and Drug Administration will outline a plan next week to streamline imports of infant formula, the agency's chief said on Friday, adding that the action along with others would "help dramatically improve the supply in the U.S. in a matter of weeks."

Reuters · May 13, 2022

House Oversight Committee launches probe into baby formula manufacturers amid nationwide shortage

‘The national formula shortage poses a threat to the health and economic security of infants and families in communities across the country,’ lawmakers write

The Independent UK · May 13, 2022